Okamoto, T.; Okajima, H.; Uebayashi, E.Y.; Ogawa, E.; Yamada, Y.; Umeda, K.; Hiramatsu, H.; Hatano, E.
Management of Epstein–Barr Virus Infection and Post-Transplant Lymphoproliferative Disorder in Pediatric Liver Transplantation. J. Clin. Med. 2022, 11, 2166.
https://doi.org/10.3390/jcm11082166
AMA Style
Okamoto T, Okajima H, Uebayashi EY, Ogawa E, Yamada Y, Umeda K, Hiramatsu H, Hatano E.
Management of Epstein–Barr Virus Infection and Post-Transplant Lymphoproliferative Disorder in Pediatric Liver Transplantation. Journal of Clinical Medicine. 2022; 11(8):2166.
https://doi.org/10.3390/jcm11082166
Chicago/Turabian Style
Okamoto, Tatsuya, Hideaki Okajima, Elena Yukie Uebayashi, Eri Ogawa, Yosuke Yamada, Katsutsugu Umeda, Hidefumi Hiramatsu, and Etsurou Hatano.
2022. "Management of Epstein–Barr Virus Infection and Post-Transplant Lymphoproliferative Disorder in Pediatric Liver Transplantation" Journal of Clinical Medicine 11, no. 8: 2166.
https://doi.org/10.3390/jcm11082166
APA Style
Okamoto, T., Okajima, H., Uebayashi, E. Y., Ogawa, E., Yamada, Y., Umeda, K., Hiramatsu, H., & Hatano, E.
(2022). Management of Epstein–Barr Virus Infection and Post-Transplant Lymphoproliferative Disorder in Pediatric Liver Transplantation. Journal of Clinical Medicine, 11(8), 2166.
https://doi.org/10.3390/jcm11082166
